Company profile: InSphero
1.1 - Company Overview
Company description
- Provider of organotypic biological in vitro 3D microtissues and microtissue-based assays for biochemical compound screening and predictive drug testing, offering human prostate and mammary carcinoma and rat liver microtissues, plus services including compound toxicity testing, cell-invasion assays, and stem-cell research.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InSphero
IBL International
HQ: Germany
Website
- Description: Provider of immunoassays and antibodies/in-vitro diagnostic assays for research, clinical, and specialty laboratories; develops, manufactures, and distributes assays focused on special and rare indications in endocrinology, neonatal screening, and the diagnosis of stress parameters and steroid hormones.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IBL International company profile →
Applied StemCell
HQ: United States
Website
- Description: Provider of animal and cell line models as tools for drug discovery and diagnostics, leveraging proprietary TARGATT gene modification technology to create site-specific knock-in mouse, rat, and human cell line models quickly and efficiently for the pharmaceutical and academic community.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied StemCell company profile →
Biosyntia
HQ: Denmark
Website
- Description: Provider of synthetic biology and metabolic engineering solutions, developing biocatalysts and tailored biocatalysis processes using patent-pending high-throughput screening. Offers BIO-B7 natural biotin (high-purity, traceable), Eraglow skincare actives based on fermented biotin, and Forskeffect botanical forskolin. Provides Biosynthetic Selections for ultra-high-throughput testing of engineered microorganisms and partnering on fermentation process development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biosyntia company profile →
Fluidic
HQ: United Kingdom
Website
- Description: Provider of tools for protein characterization, designing, developing and manufacturing instruments based on Microfluidic Diffusional Sizing (MDS) to analyze protein interactions in their native conditions without immobilization, delivering data on affinity, size and concentration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluidic company profile →
Scil Proteins
HQ: Germany
Website
- Description: Provider of discovery and development of Affilin molecules and partnerships for the development and manufacture of protein therapeutics and diagnostics. Affilin molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin, forming highly stable molecules.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scil Proteins company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InSphero
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InSphero
2.2 - Growth funds investing in similar companies to InSphero
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InSphero
4.2 - Public trading comparable groups for InSphero
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →